RBM15 overexpression partially reverses this effect, suggesting that the RBM15/KLF5 axis is a critical mediator of Irradiation of 125I radiotherapy efficacy in PAAD. The gene discussed is RBM15; the disease is pancreatic adenocarcinoma.